FCCC LOGO Faculty Publications
O'Donnell MR , Tallman MS , Abboud CN , Altman JK , Appelbaum FR , Arber DA , Attar E , Borate U , Coutre SE , Damon LE , Lancet J , Maness LJ , Marcucci G , Martin MG , Millenson MM , Moore JO , Ravandi F , Shami PJ , Smith BD , Stone RM , Strickland SA , Wang ES , Gregory KM , Naganuma M
Acute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines
Journal of the National Comprehensive Cancer Network. 2013 Sep;11(9) :1047-1055
PMID: WOS:000324310800003   
Back to previous list
Abstract
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.
Notes
O'Donnell, Margaret R. Tallman, Martin S. Abboud, Camille N. Altman, Jessica K. Appelbaum, Frederick R. Arber, Daniel A. Attar, Eyal Borate, Uma Coutre, Steven E. Damon, Lloyd E. Lancet, Jeffrey Maness, Lori J. Marcucci, Guido Martin, Michael G. Millenson, Michael M. Moore, Joseph O. Ravandi, Farhad Shami, Paul J. Smith, B. Douglas Stone, Richard M. Strickland, Stephen A. Wang, Eunice S. Gregory, Kristina M. Naganuma, Maoko